Healthcare
Prosidio Endoscope Facilitates Historic Endoscopic Pituitary Surgery in The Gambia
The first-ever endoscopic pituitary surgery in The Gambia, enabled by Prosidio's advanced endoscope, marks a significant advancement in neurosurgical care for the region.
SOUL-ED School Tour Introduces Mindfulness and Conscious Education to Philippine Classrooms
The SOUL-ED School Tour, launched by The Lighthouse Foundation, aims to transform Philippine education by integrating mindfulness and self-awareness into the curriculum to address students' mental health challenges.
Soligenix Inc. Advances Novel Immunotherapy to Combat Antibiotic Resistance
Soligenix Inc. is developing SGX943, a novel immunotherapy that enhances the body's immune response to combat bacterial infections, addressing the critical challenge of antibiotic resistance.
Lantern Pharma Inc. Harnesses AI to Revolutionize Oncology Drug Development
Lantern Pharma Inc. (NASDAQ: LTRN) is utilizing its AI-driven RADR(R) platform to accelerate the development of precision cancer therapies, marking a significant advancement in oncology drug discovery.
Cardiovascular Disease Risk Factors on the Rise Despite Medical Advances
The American Heart Association's 2025 report highlights increasing risk factors for cardiovascular diseases, signaling a pressing public health challenge.
Clene Inc. Advances Regulatory Strategy for CNM-Au8 with FDA Meetings Scheduled for ALS and MS Programs
Clene Inc. progresses in its regulatory strategy for CNM-Au8, with FDA meetings set to discuss ALS and MS treatments, marking a significant step towards potential accelerated approval.
HealthLynked Corp. Strengthens Leadership with Appointment of Andrew Mavliev as Chief Technology and Product Officer
HealthLynked Corp. enhances its technological and product development capabilities by appointing Andrew Mavliev as Chief Technology and Product Officer, signaling a strategic push towards more accessible and personalized healthcare solutions.
Tonix Pharmaceuticals Added to Russell 3000 and 2000 Indexes, Signaling Growth and Potential FDA Approval
Tonix Pharmaceuticals' inclusion in the Russell 3000 and 2000 indexes highlights its market cap growth and the potential FDA approval of TNX-102 SL for fibromyalgia, marking a significant milestone for the company.
Neutra Corp Achieves Positive Cash Flow in Q1 2025 with Expansion of Clinical Research Network
Neutra Corp's subsidiary, Neutra Life Sciences, reports a successful first quarter with the expansion of its clinical research network, signaling strong market positioning and operational efficiency.
Stem Cell and Gene Therapy Innovations Poised to Transform Medicine
The stem cell and gene therapy sectors are experiencing rapid growth, with innovations from companies like Adia Nutrition Inc., Mesoblast, Lineage Cell Therapeutics, and CRISPR Therapeutics leading the charge towards transformative treatments for serious diseases.
Siren Biotechnology and RISE Robotics Triumph at Superpowers for Good Live Pitch Q2 2025
Siren Biotechnology and RISE Robotics were recognized for their innovative contributions to cancer treatment and energy-efficient industrial motion systems at the Superpowers for Good Live Pitch, highlighting the event's role in fostering impactful entrepreneurship.
ReVessel Introduces AI-Driven Digital Twin of Human Blood for Personalized Medicine
ReVessel's development of a digital twin for human blood marks a significant advancement in personalized medicine, offering real-time, AI-powered simulations to enhance clinical decision-making.
Dr. Clark 'Cubby' Taylor Enhances Dental Care at SMILE Orthodontics & Pediatric Dentistry
Dr. Clark 'Cubby' Taylor's addition to SMILE Orthodontics & Pediatric Dentistry brings advanced expertise in orthodontics and pediatric dentistry, promising enhanced care for patients in Colorado Springs.
Desert Moon Wellness Launches GAINSWave® Therapy in Las Vegas
Desert Moon Wellness introduces GAINSWave® therapy, a non-invasive sound wave treatment aimed at enhancing circulation, sexual wellness, and recovery for both men and women, marking a significant advancement in natural health solutions.
Y2K Resurgence Fuels Keep A Breast Foundation's Merchandise Sales and Mission Impact
The Keep A Breast Foundation's strategic retail partnerships and Y2K nostalgia have significantly boosted merchandise sales, enhancing breast cancer awareness and prevention efforts.
University of Plymouth Researchers Identify Proteins Linked to Brain Tumor Growth
Researchers at the University of Plymouth have discovered proteins crucial for the growth of common brain tumors, paving the way for less invasive treatments.
UK Health Leaders Warn Against Unapproved AI Tools in Patient Care
Health leaders in England caution against the use of unapproved AI solutions for recording patient-doctor conversations, highlighting potential violations of data protection laws and risks to patient safety.
Cayenne Wellness Center Unveils The Sanctuary, a Holistic Healing Space in Glendale
The Sanctuary by Cayenne Wellness Center offers a comprehensive approach to wellness for individuals with chronic conditions, emphasizing physical, emotional, mental, and spiritual health.
Calidi Biotherapeutics Inc. Advances Oncology Pipeline and Strategic Goals in 2025
Calidi Biotherapeutics Inc. outlines significant progress in its oncology immunotherapy pipeline and strategic initiatives aimed at enhancing shareholder value and advancing cancer treatment options.
TCU Basketball Teams Join Nation of Lifesavers Through CPR Training
The TCU men's and women's basketball teams participated in Hands-Only CPR training, highlighting the importance of immediate response in cardiac emergencies to save lives.
SeaStar Medical's QUELIMMUNE Shows Promise in Treating Pediatric AKI
SeaStar Medical's QUELIMMUNE device, approved by the FDA, significantly reduces mortality rates in pediatric patients with acute kidney injury (AKI) by targeting the cytokine storm at its source.
Harpreet Singh Rai Joins Loop to Drive Preventive Health Innovation in India
Former Oura CEO Harpreet Singh Rai's appointment at Loop signifies a strategic move to enhance preventive healthcare solutions for India's workforce, aiming to add 20 healthy years to their lives.
SeaStar's QUELIMMUNE Shows Promise in Halving Pediatric Sepsis Mortality Rates
SeaStar Medical's QUELIMMUNE therapy, approved by the FDA in 2024, has demonstrated the potential to reduce pediatric sepsis mortality rates by half, offering hope for critically ill children with acute kidney injury.
Silicon Valley Aesthetic Dermatology Highlights Importance of Age-Appropriate Skin Care
Silicon Valley Aesthetic Dermatology's new blog post emphasizes the need for updating skin care routines as the body ages, offering insights into effective treatments and technologies.
Adageis Enhances Healthcare Efficiency with Value-Based Care Tools
Adageis introduces a platform simplifying operations and improving financial performance for healthcare providers transitioning to value-based care.
Scinai Immunotherapeutics Ltd. Highlights PC111 Breakthrough Following Top Italian Dermatology Award
Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) celebrates Dr. Roberta Lotti's award-winning research on PC111, a promising treatment for pemphigus vulgaris, underscoring its potential as a non-immunosuppressive therapy for autoimmune skin conditions.
Lantern Pharma's AI Platform Shows Promise in Lung Cancer Treatment
Lantern Pharma's AI-driven drug development platform, RADR®, has demonstrated significant potential in treating non-small cell lung cancer, with a Phase 2 trial patient achieving a complete response after previous treatments failed.
Annovis Bio Inc. to Showcase Alzheimer’s Research at AAIC 2025
Annovis Bio Inc. will present significant advancements in Alzheimer’s treatment at the Alzheimer’s Association International Conference 2025, highlighting the potential of its lead candidate, buntanetap.
Shift from Telehealth to In-Person Care Spurs Demand for Medical Office Space
The decline in telehealth usage post-pandemic is driving a significant demand for physical medical office spaces, particularly in urban areas like San Francisco, highlighting a broader shift in healthcare delivery preferences.
Aditxt Inc. CEO to Showcase Innovation at Wall Street Reporter’s NEXT SUPER STOCK Event
Aditxt Inc.'s CEO Amro Albanna will present the company's health innovation strategies and updates on key programs at the NEXT SUPER STOCK event, highlighting its potential impact on the healthcare sector.